Last reviewed · How we verify
Medical Management
Medical Management is a Small molecule drug developed by CVRx, Inc.. It is currently in Phase 2 development. Also known as: Antiplatelet therapy e.g. aspirin, clopidogrel, ticagrelor, dipyridamole, cilostazol, or a combination of these medications, Anticoagulation e.g warfarin, direct oral anticoagulants, misoprostol, mifepristone.
Medical Management refers to the application of various interventions, including educational programs, oral iron therapy, and point-of-care STI testing, to manage conditions such as breast cancer, iron deficiency anemia, nutrition disorders, growth retardation, and sexually transmitted infections. The effectiveness of these interventions can be evaluated through clinical trials, such as the study "Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer," which assessed the impact of a decision support system on multidisciplinary staff meeting decisions.
-
Baseline phase 2 → approval rate
+15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2031–2034 | — |
| EMA | EU | 2032–2035 | +0.7 yr |
| MHRA | GB | 2032–2035 | +0.7 yr |
| Health Canada | CA | 2032–2036 | +0.9 yr |
| TGA | AU | 2032–2036 | +1.2 yr |
| PMDA | JP | 2032–2036 | +1.5 yr |
| NMPA | CN | 2033–2037 | +2.3 yr |
| MFDS | KR | 2032–2036 | +1.4 yr |
| CDSCO | IN | 2032–2037 | +1.8 yr |
| ANVISA | BR | 2033–2037 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Medical Management |
|---|---|
| Also known as | Antiplatelet therapy e.g. aspirin, clopidogrel, ticagrelor, dipyridamole, cilostazol, or a combination of these medications, Anticoagulation e.g warfarin, direct oral anticoagulants, misoprostol, mifepristone, AAD treatment |
| Sponsor | CVRx, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A) (PHASE2)
- Learning Process of Fourth Year Medical Students During a Doctor-patient Relationship Training
- Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors (PHASE2)
- NCI COVID-19 in Cancer Patients, NCCAPS Study
- Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial (PHASE2)
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (PHASE3)
- Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical Management CI brief — competitive landscape report
- Medical Management updates RSS · CI watch RSS
- CVRx, Inc. portfolio CI
Frequently asked questions about Medical Management
What is Medical Management?
Who makes Medical Management?
Is Medical Management also known as anything else?
What development phase is Medical Management in?
Related
- Manufacturer: CVRx, Inc. — full pipeline
- Also known as: Antiplatelet therapy e.g. aspirin, clopidogrel, ticagrelor, dipyridamole, cilostazol, or a combination of these medications, Anticoagulation e.g warfarin, direct oral anticoagulants, misoprostol, mifepristone, AAD treatment
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing